Catherine Capitant

4.7k total citations
31 papers, 786 citations indexed

About

Catherine Capitant is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Catherine Capitant has authored 31 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 14 papers in Virology and 13 papers in Epidemiology. Recurrent topics in Catherine Capitant's work include HIV/AIDS Research and Interventions (21 papers), HIV Research and Treatment (14 papers) and HIV, Drug Use, Sexual Risk (9 papers). Catherine Capitant is often cited by papers focused on HIV/AIDS Research and Interventions (21 papers), HIV Research and Treatment (14 papers) and HIV, Drug Use, Sexual Risk (9 papers). Catherine Capitant collaborates with scholars based in France, Canada and United States. Catherine Capitant's co-authors include Julia Paris, S. Uzan, Gérard Bréart, M Beaufils, Jean‐Michel Molina, Laurence Meyer, Bruno Spire, Yves Lévy, Cécile Goujard and Laurence Weiss and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Catherine Capitant

30 papers receiving 759 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Capitant France 14 419 312 299 149 129 31 786
Montserrat Loncà Spain 19 868 2.1× 423 1.4× 521 1.7× 131 0.9× 42 0.3× 44 1.4k
Anna Suy Spain 17 275 0.7× 63 0.2× 241 0.8× 602 4.0× 128 1.0× 36 997
J Tricoire France 13 713 1.7× 526 1.7× 329 1.1× 43 0.3× 62 0.5× 27 1.0k
Oliver Stirrup United Kingdom 15 242 0.6× 93 0.3× 135 0.5× 147 1.0× 12 0.1× 43 571
Béatrice Barret France 6 589 1.4× 293 0.9× 258 0.9× 43 0.3× 23 0.2× 6 821
Giancarlo Orofino Italy 22 781 1.9× 487 1.6× 299 1.0× 37 0.2× 126 1.0× 75 1.3k
Nzovu Ulenga Tanzania 13 291 0.7× 130 0.4× 169 0.6× 33 0.2× 33 0.3× 43 526
Luisa Galli Italy 12 612 1.5× 440 1.4× 313 1.0× 19 0.1× 90 0.7× 20 803
Melissa R. Pfeiffer United States 11 340 0.8× 116 0.4× 240 0.8× 10 0.1× 22 0.2× 15 680
Annette Haberl Germany 18 499 1.2× 285 0.9× 310 1.0× 28 0.2× 43 0.3× 56 868

Countries citing papers authored by Catherine Capitant

Since Specialization
Citations

This map shows the geographic impact of Catherine Capitant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Capitant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Capitant more than expected).

Fields of papers citing papers by Catherine Capitant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Capitant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Capitant. The network helps show where Catherine Capitant may publish in the future.

Co-authorship network of co-authors of Catherine Capitant

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Capitant. A scholar is included among the top collaborators of Catherine Capitant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Capitant. Catherine Capitant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bauer, Rebecca, Emmanuelle Netzer, Claire Pintado, et al.. (2020). Coverage of Sex Acts by Event-Driven Pre-exposure Prophylaxis: A Sub-Study of the ANRS IPERGAY Trial. AIDS and Behavior. 24(11). 3244–3251. 8 indexed citations
2.
Sagaon‐Teyssier, Luis, Marie Suzan‐Monti, Christel Protière, et al.. (2020). Changes in Sexual Behaviors in Men Who Have Sex with Men: A Comparison Between the Double-Blind and Open-Label Extension Phases of the ANRS-IPERGAY Trial. AIDS and Behavior. 24(11). 3093–3106. 5 indexed citations
3.
Sagaon‐Teyssier, Luis, Lisa Fressard, Marie Suzan‐Monti, et al.. (2018). A Group-Based Trajectory Model for Changes in Pre-Exposure Prophylaxis and Condom Use Among Men Who Have Sex with Men Participating in the ANRS IPERGAY Trial. AIDS Patient Care and STDs. 32(12). 495–510. 7 indexed citations
4.
Suzan‐Monti, Marie, Laurent Cotte, Lisa Fressard, et al.. (2018). Factors associated with partner notification of STIs in men who have sex with men on PrEP in France: a cross-sectional substudy of the ANRS-IPERGAY trial. Sexually Transmitted Infections. 94(7). 490–493. 4 indexed citations
5.
Delaugerre, Constance, Christophe Rodriguez, Catherine Capitant, et al.. (2018). Drug resistance among patients who acquired HIV infection in a preexposure prophylaxis trial. AIDS. 32(16). 2353–2361. 9 indexed citations
6.
Alvarez, Jean‐Claude, Rebecca Bauer, Perrine Roux, et al.. (2018). Consommation de drogues identifiée par analyse capillaire parmi les HSH lors de l’étude ANRS Ipergay : relation avec les pratiques à risque. Annales de Toxicologie Analytique. 30(2). S45–S46. 2 indexed citations
7.
Durand‐Zaleski, Isabelle, Isabelle Charreau, Cécile Tremblay, et al.. (2017). Costs and benefits of on-demand HIV preexposure prophylaxis in MSM. AIDS. 32(1). 95–102. 24 indexed citations
8.
Delaugerre, Constance, Guillemette Antoni, Nadia Mahjoub, et al.. (2017). Assessment of HIV Screening Tests for Pre-Exposure Prophylaxis Programs. The Journal of Infectious Diseases. 216(3). 382–386. 21 indexed citations
9.
Sagaon‐Teyssier, Luis, Marie Suzan‐Monti, Baptiste Demoulin, et al.. (2016). Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial. AIDS Care. 28(sup1). 48–55. 65 indexed citations
10.
Fonsart, Julien, Sentob Saragosti, Gilles Peytavin, et al.. (2016). Single-dose pharmacokinetics and pharmacodynamics of oral tenofovir and emtricitabine in blood, saliva and rectal tissue: a sub-study of the ANRS IPERGAY trial. Journal of Antimicrobial Chemotherapy. 72(2). 478–485. 37 indexed citations
11.
Larrouy, Lucile, Charlotte Charpentier, Roland Landman, et al.. (2011). Dynamics of gag-pol minority viral populations in naive HIV-1-infected patients failing protease inhibitor regimen. AIDS. 25(17). 2143–2148. 2 indexed citations
12.
Lorente, Nicolas, Lionel Fugon, Patrizia Carrieri, et al.. (2011). Acceptability of an “on-demand” pre-exposure HIV prophylaxis trial among men who have sex with men living in France. AIDS Care. 24(4). 468–477. 40 indexed citations
13.
Larrouy, Lucile, Corine Chazallon, Roland Landman, et al.. (2010). Gag Mutations Can Impact Virological Response to Dual-Boosted Protease Inhibitor Combinations in Antiretroviral-Naive HIV-Infected Patients. Antimicrobial Agents and Chemotherapy. 54(7). 2910–2919. 25 indexed citations
14.
Landman, Roland, Catherine Capitant, Diane Descamps, et al.. (2009). Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study. Journal of Antimicrobial Chemotherapy. 64(1). 118–125. 7 indexed citations
15.
Durier, Christine, Catherine Capitant, Anne‐Sophie Lascaux, et al.. (2007). Long-term effects of intermittent interleukin-2 therapy in chronic HIV-infected patients (ANRS 048–079 Trials)*. AIDS. 21(14). 1887–1897. 22 indexed citations
16.
Lévy, Yves, Christine Durier, Roman Krzysiek, et al.. (2003). Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection. AIDS. 17(3). 343–351. 82 indexed citations
17.
Gougeon, Marie‐Lise, Christine Rouzioux, Marianne Burgard, et al.. (2001). Immunological and virological effects of long term IL-2 therapy in HIV-1-infected patients. AIDS. 15(13). 1729–1731. 27 indexed citations
18.
Lévy, Yves, Catherine Capitant, Sami Houhou, et al.. (1999). Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial. The Lancet. 353(9168). 1923–1929. 116 indexed citations
19.
Zou, Weiping, Arnaud Foussat, Catherine Capitant, et al.. (1999). Acute Activation of CD8+ T Lymphocytes in Interleukin-2–Treated HIV-Infected Patients. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 22(1). 31–31. 13 indexed citations
20.
Beaufils, M, et al.. (1990). PREVENTION OF PREECLAMPSIA WITH LOW-DOSE ASPIRIN : RESULTS OF THE EPREDA TRIAL. Journal of Perinatal Medicine. 18(s1). 116–116. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Montserrat Loncà Breakdown of academic impact, for papers by Anna Suy Breakdown of academic impact, for papers by J Tricoire Breakdown of academic impact, for papers by Oliver Stirrup Breakdown of academic impact, for papers by Béatrice Barret Breakdown of academic impact, for papers by Giancarlo Orofino Breakdown of academic impact, for papers by Nzovu Ulenga Breakdown of academic impact, for papers by Luisa Galli Breakdown of academic impact, for papers by Melissa R. Pfeiffer Breakdown of academic impact, for papers by Annette Haberl
Rankless by CCL
2026